Effects of nicotine withdrawal on central dopaminergic systems.
paper
Cited
Public
Unavailable
- Authors
- Fung, Y K; Schmid, M J; Anderson, T M; Lau, Y S
- Year
- 1996
- Journal
- Pharmacology, biochemistry, and behavior
- PMID
- 8866966
- DOI
- 10.1016/0091-3057(95)02063-2
The behavioral and neurochemical manifestations in rats 24 h following the cessation of 14-day nicotine administration were investigated. Animals were implanted subcutaneously with osmotic minipumps which continuously released either saline or nicotine (1.5 mg/kg/day or 3.0 mg/kg/day) for 14 days. After the animals were withdrawn from nicotine for 24 h, we observed a significant decrease of locomotor activities and a reduction of dopamine contents in the striatum and nucleus accumbens. Nicotine withdrawal did not affect the body weight, food, or water consumption, and no deficit in the acquisition of a conditioned avoidance task was found in these animals. In addition, nicotine withdrawal did not alter the density or the binding affinity (Kd) of ligands to D1 and D2 receptors in the striatum. Although nicotine withdrawal did not alter the density or binding affinity of ligands to D1 receptors in the nucleus accumbens, the maximum number of D2 receptor sites were reduced by nicotine treatment. These results offer possible neurochemical mechanisms for changes of locomotor activity which occurred in rats during nicotine abstinence.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke. | 2017 | 27067016 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Adolescent nicotine abstinence increases anxiety and depressive-like behaviors, alcohol consumption, oxidative stress and inflammatory response accompanied by attenuated serotonergic/dopaminergic and cholinergic function in rats. | Ahmadi-Soleimani SM et al. | β | 2025 | β |
| Changes in Locomotor Activity Observed During Acute Nicotine Withdrawal Can Be Attenuated by Ghrelin and GHRP-6 in Rats. | Ayman J et al. | β | 2025 | β |
| The involvement of dopamine and D2 receptor-mediated transmission in effects of cotinine in male rats. | Tan X et al. | β | 2023 | β |
| Chronic Lorcaserin Treatment Reverses the Nicotine Withdrawal-Induced Disruptions to Behavior and Maturation in Developing Neurons in the Hippocampus of Rats. | Zaniewska M et al. | β | 2021 | β |
| GABA<sub>B</sub> receptors blockage modulates somatic and aversive manifestations induced by nicotine withdrawal. | Varani AP et al. | β | 2021 | β |
| A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke. | Jensen KP et al. | β | 2017 | β |
| Nicotinic receptor blockade decreases fos immunoreactivity within orexin/hypocretin-expressing neurons of nicotine-exposed rats. | Simmons SJ et al. | β | 2016 | β |
| Lack of GABAB receptors modifies behavioural and biochemical alterations induced by precipitated nicotine withdrawal. | Varani AP et al. | β | 2015 | β |
| The effect of nicotine induced behavioral sensitization on dopamine D1 receptor pharmacology: An in vivo and ex vivo study in the rat. | Goutier W et al. | β | 2015 | β |
| Baclofen prevented the changes in c-Fos and brain-derived neutrophic factor expressions during mecamylamine-precipitated nicotine withdrawal in mice. | Varani AP et al. | β | 2014 | β |
| Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation. | Li X et al. | β | 2014 | β |
| Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems. | Mackowick KM et al. | β | 2014 | β |
| Trait differences in response to chronic nicotine and nicotine withdrawal in rats. | Kolokotroni KZ et al. | β | 2014 | β |
| Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking. | Cohen A et al. | β | 2013 | β |
| Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat. | Malin DH et al. | β | 2013 | β |
| Mecamylamine-precipitated nicotine withdrawal syndrome and its prevention with baclofen: an autoradiographic study of Ξ±4Ξ²2 nicotinic acetylcholine receptors in mice. | Varani AP et al. | β | 2013 | β |
| Stress response dysregulation and stress-induced analgesia in nicotine dependent men and women. | al'Absi M et al. | β | 2013 | β |
| Acute behavioural responses to nicotine and nicotine withdrawal syndrome are modified in GABA(B1) knockout mice. | Varani AP et al. | β | 2012 | β |
| Adolescent rats are resistant to adaptations in excitatory and inhibitory mechanisms that modulate mesolimbic dopamine during nicotine withdrawal. | Natividad LA et al. | β | 2012 | β |
| Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal. | Varani AP et al. | β | 2011 | β |
| Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats. | Ohmura Y et al. | β | 2011 | β |
| Effects of acute and repeated nicotine administration on delay discounting in Lewis and Fischer 344 rats. | Anderson KG et al. | β | 2010 | β |
| Neuromodulation of decision-making in the addictive brain. | Fecteau S et al. | β | 2010 | β |
| The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats. | Semenova S et al. | β | 2010 | β |
| The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer. | Improgo MR et al. | β | 2010 | β |
| Tobacco addiction: a biochemical model of nicotine dependence. | Ortells MO et al. | β | 2010 | β |
| Cellular events in nicotine addiction. | Penton RE et al. | β | 2009 | β |
| Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. | Morisano D et al. | β | 2009 | β |
| Nicotine dependence: biology, behavior, and treatment. | Ray R et al. | β | 2009 | β |
| Rodent models of nicotine withdrawal syndrome. | Malin DH et al. | β | 2009 | β |
| Animal models and treatments for addiction and depression co-morbidity. | Paterson NE et al. | β | 2007 | β |
| Bupropion attenuates nicotine abstinence syndrome in the rat. | Malin DH et al. | β | 2006 | β |
| Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study. | McBride D et al. | β | 2006 | β |
| Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome. | Besson M et al. | β | 2006 | β |
| Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. | Xu J et al. | β | 2005 | β |
| Co-morbidity of smoking in patients with psychiatric and substance use disorders. | Kalman D et al. | β | 2005 | β |
| Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation. | Powell JH et al. | β | 2004 | β |
| Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats. | Shoaib M et al. | β | 2004 | β |
| Long-term, low-level adolescent nicotine exposure produces dose-dependent changes in cocaine sensitivity and reward in adult mice. | Kelley BM et al. | β | 2004 | β |
| Measuring the emergence of tobacco dependence: the contribution of negative reinforcement models. | Eissenberg T | β | 2004 | β |
| Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study. | Rahman S et al. | β | 2004 | β |
| Neuroendocrinological and neuropsychological correlates of dopaminergic function in nicotine dependence. | Smolka MN et al. | β | 2004 | β |
| Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. | Sacco KA et al. | β | 2004 | β |
| A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation. | George TP et al. | β | 2003 | β |
| Chronic exposure of nicotine modulates the expressions of the cerebellar glial glutamate transporters in rats. | Lim DK et al. | β | 2003 | β |
| Impact of nicotine withdrawal on novelty reward and related behaviors. | Besheer J et al. | β | 2003 | β |
| Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. | Le Foll B et al. | β | 2003 | β |
| Nicotine lowers the body-weight set-point in male rats. | Frankham P et al. | β | 2003 | β |
| Lasting effects of adolescent nicotine exposure on the electroencephalogram, event related potentials, and locomotor activity in the rat. | Slawecki CJ et al. | β | 2002 | β |
| Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model. | Powell J et al. | β | 2002 | β |
| The potential of dopamine agonists in drug addiction. | Kosten TR et al. | β | 2002 | β |
| Changes in the glutamate release and uptake of cerebellar cells in perinatally nicotine-exposed rat pups. | Lim DK et al. | β | 2001 | β |
| Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. | Dagher A et al. | β | 2001 | β |
| A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. | Roll JM et al. | β | 2000 | β |
| Determinants of the voluntary consumption of nicotine by rats. | Maehler R et al. | β | 2000 | β |
| Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice. | GΓ€ddnΓ€s H et al. | β | 2000 | β |
| Influence of various drugs on the voluntary intake of nicotine by rats. | Kameda G et al. | β | 2000 | β |
| Subacute nicotine exposure in cultured cerebellar cells increased the release and uptake of glutamate. | Lim DK et al. | β | 2000 | β |
| Mecamylamine-precipitated nicotine-withdrawal aversion in Lewis and Fischer 344 inbred rat strains. | Suzuki T et al. | β | 1999 | β |
| Nicotine abstinence in the mouse. | Isola R et al. | β | 1999 | β |
| Nicotine's effect on hypothalamic neurotransmitters and appetite regulation. | Miyata G et al. | β | 1999 | β |
| Chronopharmacological effects on nicotine repeated administration on heart rate, body temperature and locomotor activity circadian rhythms in rats. | Pelissier AL et al. | β | 1998 | β |
| Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress. | George TP et al. | β | 1998 | β |
| Nicotine-induced perturbations on heart rate, body temperature and locomotor activity daily rhythms in rats. | Pelissier AL et al. | β | 1998 | β |
| Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. | Hildebrand BE et al. | β | 1998 | β |
| Short-term effects of nicotine on bone and calciotropic hormones in adult female rats. | Fung YK et al. | β | 1998 | β |
| Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron. | Suzuki T et al. | β | 1997 | β |
| Tobacco smoke influence on heart rate, body temperature, and locomotor activity daily rhythms as assessed by radiotelemetry in rats. | Pelissier AL et al. | β | 1997 | β |
| An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. | Roll JM et al. | β | 1996 | β |
| Mecamylamine-precipitated nicotine-withdrawal aversion in rats. | Suzuki T et al. | β | 1996 | β |